Andre Zagorski is senior principal technical advisor in MSH’s Pharmaceuticals and Health Technologies (PHT) Group, in charge of developing TB strategies and interventions to ensure universal access to anti-TB medicines, regimens and new technologies in line with the USAID and WHO goals of ending the TB epidemic.

Dr. Dubuche, MD, MPH, is a medical doctor, an obstetrician and gynecologist, and a public health specialist. He first joined MSH as Technical Director for the USAID-funded Santé pour le Développement et la Stabilité d’Haïti (SDSH) Project and currently serves as Chief of Party for the USAID Haiti Health Leadership Project.

Zeine Abosse, MPH, BSc, is a technical advisor for the USAID-funded Health Workforce Improvement Program (HWIP) Project in Ethiopia. A public health specialist, Abosse has over 28 years of experience in designing, managing, and implementing public health programs in the areas of human resources for health (HRH), maternal and child health, integrated child health services, TB and HIV and AIDS prevention and control, disease prevention and health promotion, and integrated disease surveillance and epidemic control...

Héctor Castro, MD, PhD, Global Lead of Infectious Diseases, Health Financing, Technologies, Data, and Impact at MSH, has nearly 20 years of global health experience with a focus on health systems strengthening in quality assurance, assessment, health financing, strategic purchasing, and provision of health care technologies (including medicines, devices, and procedures).